Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection

AIDS Research and Human Retroviruses

Volumn 12, Issue 11, 1996, Pages 1053-1061

  Clerici, Mario ^a,c   Balotta, Claudia ^a   Meroni, Luca ^a   Ferrario, Enrica ^a   Riva, Chiara ^a   Trabattoni, Daria ^a   Ridolfo, Annalisa ^a   Villa, Marialuisa ^a   Shearer, Gene M ^b   Moroni, Mauro ^a   Galli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOPHENOTYPING; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS ISOLATION;

EID: 0029759570     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1053     Document Type: Article

References (44)

1. Clerici M and Shearer GM: A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
2. Clerici M and Shearer GM: The TH1/TH2 model of HIV infection: New insights. Immunol Today 1994;15:575-581.
3. Meeyard L, Otto SA, Keet IPM, Van Lier RAW, and Miedema F: Changes in cytokine secretion patterns of CD4+ T cell clones in HIV infection. Blood 1994;84:4262-4270.
4. Barcellini W, Rizzardi GP, Borghi MO, et al.: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994;8:757-762.
5. Giorgi JV, Fahey JL, Smith DC, et al.: Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987;138:3725-3730.
6. Miedema F, Petit AJ, Terpstra FG, et al.: Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988;82:1908-1916.
7. Clerici M, Stocks NI, Zajac RC, et al.: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989;84: 1892-1899.
8. Chehimi J, Starr SE, Frank I, et al.: IL-12 deficiency in HIV-infected patients. J Exp Med 1994;179:1361-1366.
9. Clerici M, Hakim FT, Venzon DJ, et al.: Changes in interleukin 2 and interleukin 4 production in asymptomatic, HIV-seropositive individuals. J Clin Invest 1993;91:759-765.
10. Naviskas V, Link J, Warhen B, Pearsson C, and Link H: Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994; 96:59-63.
11. Lafeiullade A: Increased interleukin-6 production is associated with disease progression in HIV infection. AIDS 1991;5:1139-1140.
12. Clerici M, Wynn TA, Berzofsky JA, et al.: Role of interleukin-10 (IL-10) in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus (HIV-1). J Clin Invest 1994;93:768-775.
13. Emilie D, Fior L, Llorente A, et al.: Cytokines from lymphoid organs of HIV-infected patients: Production and role in the immune disequilibrium of the disease and in development of B lymphomas. Immunol Rev 1994;140:5-35.
14. Akridge RE, Oyafuso LKM, and Reed SG: IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994;153:5782-5788.
15. Lucey DR, Melcher GP, Hendrix CW, and the USAF HIV Study Group: The U.S. Air Force HIV study 1985-1990: Immunological analyses, seroconversion and the potential utility of a T-helper functional assay to predict change in CD4+ T-cell counts during early stage HIV infection. J Infect Diseases 1991;164:631-637.
16. bright cells is predictive of death in HIV infection. J Infect Dis 1995;172:79-87.
17. Asijo B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lidman K, and Fenyö EM; Replicative capacity of human immunodeficiency virus from patients with varying severity of infection. Lancet 1986;ii:660-662.
18. Ho DD, Moudgil T, and Masud A: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-1625.
19. Coombs RW, Collier AC, Allain J-P, Nikora B, Leuther M, Gjerset GF, and Corey L: Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;32:1626-1625.
20. Bagnarelli P, Valenza A, Menzo S, Manzin A, Scalise G, Varaldo P, and Clementi M: Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol 1994;68: 2495-2502.
21. Greene WC: The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:308-317.
22. Ho H-N, Hultin LE, Mitsuya RT, et al.: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993;150:3070-3079.
23. Legac E, Autran B, Merle-Beral H, Katlama C, and Debre P: CD4+CD7-CD57+ T cells: A new T lymphocyte subset expanded during HIV infection. Blood 1992;79:1746-1753.
24. Autran B, Legac E, Blanc C, and Debré P: A Th0/Th2-like function of CD4+ CD7-T helper cells from normal donors and HIV infected patients. J Immunol 1995;154:1408-1417.
25. Levy JA: HIV pathogenesis and long-term survival. AIDS 1993;7: 1401-1418.
26. Tovo PA, De Martino M, Gabiano C, et al.: Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992;339:1249-1253.
27. Clerici M, Roilides E, Butler KM, et al.: Changes in T helper cell function in human immunodeficiency virus infected children during dideoxynosine therapy as a measure of antiretroviral activity. Blood 1992;80:2196-2102.
28. Keet IPM, Krol A, Klein MR, et al.: Long-term asymptomatic HIV-1 infection with normal and low CD4 counts. J Infect Dis 1994;169:1236-1241.
29. Gotch FM, Rowland-Jones S, and Nixon DF: Longitudinal studies of HIV Gag-specific cytotoxic T lymphocyte responses over time in several patients. In: Cytotoxic T Cells in HIV Infection (Racz P, Letvin NL, and Gluckman JC, eds.). Karger, Basel, 1992, p. 60.
30. Riviere Y, McChesney M, Porrot F, et al.: Role of HIV specific cytotoxic effector cells in disease progression. XI International Conference on AIDS. Berlin, Germany, 6-11 June 1993. [Abstract WS B 03-4]
31. Lucey DR, Zajac RA, Melcher GP, et al.: Serum IgE levels in 622 persons with HIV infection: IgE elevation with marked depletion of CD4+ T-cells. AIDS Res Hum Retroviruses 1990;6:427-429.
32. Vigane A, Crupi L, Principi N, and Salvaggio A: Elevation of IgE in HIV-infected children and its correlation with the progression of the disease. J Allergy Clin Immunol 1995;95:627-632.
33. Smith KJ, Skelton HG, Drabick JJ, McCarthy WF, Ledsky R, and Wagner KF: Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. Arch Dermatol 1994;130:119-121.
34. Viganò A, Principi N, Villa ML, et al.: Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression. J Pediatr 1995;126:368-374.
35. Nara P, Hatch W, Kessler J, Kelliher J, and Carter S: The biology of HIV-1 IIIB infection in the chimpanzee: In vivo and in vitro correlations. J Med Primatol 1989;18:343-355.
36. Heeney J, Jonker R, Koornstra W, et al.: The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T cell dysfunction. J Med Primatol 1993;22: 194-200.
37. - long term survivor. AIDS Res Hum Retroviruses 1994;10: 1703-1711.
38. Cao Y, Qin L, Zhang L, et al.: Virologic and immunologic characterization of long-term survivors of HIV type 1 infection. N Engl J Med 1995;332:201-208.
39. Pantaleo G, Menzo S, Vaccarezza M, et al.: Studies in subjects with long-term nonprogressive HIV infection. N Engl J Med 1995; 332:209-216.
40. Barnes DM: HIV-1 infected long term non-progressors: A distinct group or part of a continuum? J NIH Res 1995;7:19-21.
41. Rinaldo C, Huang X-L, Fan Z, et al.: High levels of anti HIV-1 memory cytotoxic T lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long term nonprogressors. J Virol 1995;69:5838-5844.
42. Koot M, Keet IPM, Vos AHV, et al.: Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4 depletion and progression to AIDS. Ann Intern Med 1993; 118:681-688.
43. Schuitemaker H, Koot M, Koostra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus population. J Virol 1992;66:1354-1360.
44. Balotta C, Bagnarelli P, Riva G, et al.: Biological and molecular events in long term non progressive patients. AIDS Res Hum Retroviruses 1995;11(Supp. 1):S84.